Literature DB >> 15019275

Susceptibility of mast cell-deficient W/Wv mice to pristane-induced experimental lupus nephritis.

Ling Lin1, Andrea J Gerth, Stanford L Peng.   

Abstract

In many models of organ-specific autoimmune diseases, mast cells provide a critical cellular link between autoantibodies and end-organ inflammation, both initiating and propagating disease. However, their role in systemic autoimmunity remains speculative. We therefore examined the role of mast cells in a murine model of systemic immune complex-related autoimmune disease, lupus nephritis, expecting to observe the development of humoral autoimmunity in the absence of end-organ disease. Surprisingly, not only did mast cell-deficient animals develop characteristic humoral features of lupus, including hypergammaglobulinemia and autoantibodies, they also developed immune complex glomerulonephritis, as evidenced by renal immune deposits, glomerular disease, and proteinuria. These findings implicate the presence of distinct effector pathways to end-organ damage in humoral autoimmune diseases: one involving the interaction between autoantibodies and mast cells to recruit inflammation in organ-specific autoimmunity, and another involving a more direct--mast cell-independent--interaction between autoantibodies and circulating inflammatory mediators in systemic autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019275     DOI: 10.1016/j.imlet.2003.11.014

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

Review 1.  Leukocytes in glomerular injury.

Authors:  Stephen R Holdsworth; Peter G Tipping
Journal:  Semin Immunopathol       Date:  2007-10-16       Impact factor: 9.623

2.  Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency.

Authors:  Annemarie Em van Nieuwenhuijze; Bénédicte Cauwe; Denise Klatt; Stéphanie Humblet-Baron; Adrian Liston
Journal:  Immunol Cell Biol       Date:  2015-04-07       Impact factor: 5.126

3.  Unique populations of lung mast cells are required for antigen-mediated bronchoconstriction.

Authors:  J M Cyphert; M Kovarova; B H Koller
Journal:  Clin Exp Allergy       Date:  2010-08-16       Impact factor: 5.018

Review 4.  IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target.

Authors:  Yasmine Lamri; Nicolas Charles
Journal:  Antibodies (Basel)       Date:  2020-12-08

5.  Mast cell regulation of the immune response.

Authors:  John J Ryan; Johanna K Morales; Yves T Falanga; Josephine F A Fernando; Matthew R Macey
Journal:  World Allergy Organ J       Date:  2009-10       Impact factor: 4.084

Review 6.  Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Massimo Costanza; Mario P Colombo; Rosetta Pedotti
Journal:  Int J Mol Sci       Date:  2012-11-16       Impact factor: 5.923

7.  SH2D1A regulates T-dependent humoral autoimmunity.

Authors:  Jonathan D Hron; Liron Caplan; Andrea J Gerth; Pamela L Schwartzberg; Stanford L Peng
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.